The prospective evaluation of the TB strain typing service in England: A mixed methods study

Thorax

Volumn 71, Issue 8, 2016, Pages 734-741

  Mears, J ^a   Vynnycky, E ^b,c   Lord, J ^d   Borgdorff, M W ^e,f   Cohen, T ^g   Crisp, D ^h   Innes, J A ⁱ   Lilley, M ^b   Maguire, H ^b   McHugh, T D ^a   Woltmann, G ^j   Abubakar, I ^k   Sonnenberg, P ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d BRUNEL UNIVERSITY   (United Kingdom)

^e DEPARTMENT OF INFECTIOUS DISEASES   (Netherlands)

^f UNIVERSITY OF AMSTERDAM   (Netherlands)

^g YALE UNIVERSITY   (United States)

^h GEORGE ELIOT HOSPITAL NHS TRUST   (United Kingdom)

ⁱ BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^j GLENFIELD HOSPITAL   (United Kingdom)

^k MEDICAL RESEARCH COUNCIL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIUM IDENTIFICATION; CAUCASIAN; CONTACT EXAMINATION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DELAYED DIAGNOSIS; ENGLAND; FALSE POSITIVE RESULT; HUMAN; INCIDENCE; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MATHEMATICAL MODEL; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEMI STRUCTURED INTERVIEW; TUBERCULOSIS CONTROL; TUBERCULOSIS STRAIN TYPING SERVICE; UNITED KINGDOM; COST BENEFIT ANALYSIS; ECONOMICS; GENETICS; HEALTH SERVICE; HEALTH SURVEY; ISOLATION AND PURIFICATION; MICROBIOLOGY; PROCEDURES; PROGRAM EVALUATION; PUBLIC HEALTH; STANDARDS; TUBERCULOSIS, PULMONARY;

BACTERIAL TYPING TECHNIQUES; COST-BENEFIT ANALYSIS; ENGLAND; HEALTH SERVICES; HUMANS; INCIDENCE; MYCOBACTERIUM TUBERCULOSIS; POPULATION SURVEILLANCE; PROGRAM EVALUATION; PROSPECTIVE STUDIES; PUBLIC HEALTH; TUBERCULOSIS, PULMONARY;

EID: 84930392257     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2014-206480     Document Type: Article

References (30)

1. Department of Health. 100,000 Genomes Project [Internet] (cited 4 June 2014). http://www.genomicsengland.co.uk/100k-genome-project
2. Public Health England. National TB Strategy 2014-2019 Consultation [Internet]. (cited 1 Jul 2014). http://www.hpa.org.uk/Publications/InfectiousDiseases/Tuberculosis/1403TBstrategyconsultation2014/
3. Department of HealthDonaldson SL. Stopping tuberculosis in England: an action plan from the Chief Medical Officer [Internet]. 2004 (cited 11 Apr 2012). http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicy AndGuidance/DH-4090417
4. Supply P, Allix C, Lesjean S, et al. Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. J Clin Microbiol 2006;44:4498-510.
5. Public Health England. TB Strain Typing and Cluster Investigation Handbook 3rd Edition [Internet]. 2014 (cited 4 Jun 2014). http://www.hpa.org.uk/webc/HPAwebFile/HPAweb-C/1317140774833
6. Brown T, Evans JT, Sails AD, et al. HPA Mycobacterium tuberculosis Strain Typing: a guide to data production and distribution. HPA, 2012.
7. Campbell M, Fitzpatrick R, Haines A, et al. Framework for design and evaluation of complex interventions to improve health. BMJ 2000;321:694-6.
8. Mears J, Abubakar I, Crisp D, et al. Prospective evaluation of a complex public health intervention: lessons from an initial and follow-up cross-sectional survey of the Tuberculosis Strain Typing Service in England. BMC Public Health 2014;14:1023.
9. Vynnycky E, Fine PE. The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection. Epidemiol Infect 1997;119:183-201.
10. Vynnycky E, Sumner T, Fielding KL, et al. Tuberculosis control on South African goldmines: mathematical modelling of a trial of community-wide isoniazid preventive therapy. Am J Epidemiol, in press.
11. Office for National Statistics. Migration indicators tool. ONS, 2010.
12. National Institute of Health and Care Excellence. Methods for development of NICE public health guidance [Internet]. 2009 (cited 14 Dec 2011). http://www.nice.org. uk/phmethods2009
13. Department of Health. NHS Reference Costs 2010-11 Collection Guidance [Internet]. 2010 (cited 30 Nov 2011). http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH-122803
14. PSSRU|Unit Costs of Health and Social Care 2011 [Internet]. (cited 13 Apr 2012). http://www.pssru.ac.uk/project-pages/unit-costs/2011/index.php
15. Crofts JP, Pebody R, Grant A, et al. Estimating tuberculosis case mortality in England and Wales, 2001-2002. Int J Tuberc Lung Dis 2008;12: 308-13.
16. Kruijshaar ME, Lipman M, Essink-Bot M-L, et al. Health status of UK patients with active tuberculosis. Int J Tuberc Lung Dis 2010;14:296-302.
17. House of Commons Health Committee. Health Inequalities. House of Commons, London; 2009 Mar p. 28. Report No. Volume I.
18. Sheringham J, Baraitser P, Simms I, et al. Chlamydia screening in England: a qualitative study of the narrative behind the policy. BMC Public Health 2012;12:317.
19. Veen J. Microepidemics of tuberculosis: the stone-in-the-pond principle. Tuber Lung Dis 1992;73:73-6.
20. De Beer JL, van Ingen J, de Vries G, et al. Comparative study of IS6110 restriction fragment length polymorphism and variable-number tandem-repeat typing of Mycobacterium tuberculosis isolates in the Netherlands, based on a 5-year nationwide survey. J Clin Microbiol 2013;51:1193-8.
21. Bryant JM, Schürch AC, van Deutekom H, et al. Inferring patient to patient transmission of Mycobacterium tuberculosis from whole genome sequencing data. BMC Infect Dis 2013;13:110.
22. De Vries G, van Hest RAH, Richardus JH. Impact of mobile radiographic screening on tuberculosis among drug users and homeless persons. Am J Respir Crit Care Med 2007;176:201-7.
23. Ruddy MC, Davies AP, Yates MD, et al. Outbreak of isoniazid resistant tuberculosis in north London. Thorax 2004;59:279-85.
24. Malakmadze N, González IM, Oemig T, et al. Unsuspected recent transmission of tuberculosis among high-risk groups: implications of universal tuberculosis genotyping in its detection. Clin Infect Dis 2005;40:366-73.
25. Lambregts-van Weezenbeek CSB, Sebek MMGG, van Gerven PJHJ, et al. Tuberculosis contact investigation and DNA fingerprint surveillance in The Netherlands: 6 years' experience with nation-wide cluster feedback and cluster monitoring. Int J Tuberc Lung Dis 2003;7(12 Suppl 3):S463-470.
26. Borgdorff MW, van Soolingen D. The re-emergence of tuberculosis: what have we learnt from molecular epidemiology? Clin Microbiol Infect 2013;19: 889-901.
27. Walker TM, Ip CL, Harrell RH, et al. Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study. Lancet Infect Dis 2013;13:137-46.
28. Small PM, Shafer RW, Hopewell PC, et al. Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection. N Engl J Med 1993;328:1137-44.
29. Borgdorff MW, van den Hof S, Kremer K, et al. Progress towards tuberculosis elimination: secular trend, immigration and transmission. Eur Respir J 2010;36:339-47.
30. De Beer JL, Kodmon C, van der Werf MJ, et al., ECDC MDR-TB Molecular Surveillance Project Participants. Molecular surveillance of multi-And extensively drug-resistant tuberculosis transmission in the European Union from 2003 to 2011. Euro Surveill 2014;19:pii: 20742.